有机化学人才网 | 最新人才 | 最新职位 | 技术交易 | 药物合成 |
   
全站搜索: |
  您当前位置:网站首页 >> 药物合成路线图解
 

药物详细合成路线

Name Valganciclovir hydrochloride;TA-9070;Ro-10-79070/194;RS-79070-194;RS-79070(free base);Valcyte;Valcyt;Cymeval
Chemical Name 5-Amino-3-[1-(hydroxymethyl)-2-(L-valyloxy)ethoxymethyl]-6,7-dihydro-3H-imidazo[4,5-d]pyrimidin-7-one hydrochloride
      L-Valine 2-(guanin-9-ylmethoxy)-3-hydroxypropyl ester hydrochloride
CAS 175865-59-5
Related CAS 175865-67-5 ((R)-isomer), 175865-62-0 ((R)-isomer, free base), 175865-63-1 ((R)-isomer, monoacetate
Formula C14H23ClN6O5
Structure
Formula Weight 390.82961
Stage 上市-2001
Company Roche (Originator), Tanabe Seiyaku (Marketer), Recordati (Licensee)
Activity/Mechanism Anti-Cytomegalovirus Drugs, ANTIINFECTIVE THERAPY, Antiviral Drugs, Chemical Delivery Systems, DRUG DELIVERY, Drug Delivery Systems
Syn. Route 6
Route 1
the silylation of ganciclovir (i) with tmscl and imidazole in dmf gives the n2-silylated compound (ii), which by condensation with n-benzyloxycarbonyl-l-valine-n-carboxyanhydride (iii) and subsequent treatment with 3m hcl yields the monoprotected valganciclovir derivative (iv). finally, this compound is submitted to hydrogenolysis with h2 over pd/c in methanol/hcl.
List of intermediates No.
(3-[6-[3-(4-methoxyphenyl)-1,2-diboriran-3-yl]hexaboranyl]-1,2-diboriran-3-yl)methanol (iii)
2-(tert-butyl)-1,3,4-oxadiazole (i)
tert-butyl (1s)-1-formyl-2-methylpropylcarbamate (ii)
tert-butyl (1s)-1-[[5-(tert-butyl)-1,3,4-oxadiazol-2-yl](hydroxy)methyl]-2-methylpropylcarbamate (iv)
Reference 1:
    sorbera, l.a.; casta?er, j.; casta?er, r.m.; valganciclovir hydrochloride. drugs fut 2000, 25, 5, 474.
Reference 2:
    arzeno, h.b.; beard, c.c.; fisher, l.e.; prince, a. (f. hoffmann-la roche ag); process for preparing purine derivs.. wo 9727194 .

Route 2
the condensation of ganciclovir (i) with the activated l-valine derivative (iii) by means of triethylamine in dmf gives the o,o-bis(valyl)ganciclovir derivative (v), which by selective removal of one of the l-valine groups with propylamine in hexane yields the previously reported monoprotected valganciclovir derivative (iv).
List of intermediates No.
(3-[6-[3-(4-methoxyphenyl)-1,2-diboriran-3-yl]hexaboranyl]-1,2-diboriran-3-yl)methanol (iii)
2-(tert-butyl)-1,3,4-oxadiazole (i)
tert-butyl (1s)-1-[[5-(tert-butyl)-1,3,4-oxadiazol-2-yl](hydroxy)methyl]-2-methylpropylcarbamate (iv)
(2s)-2-amino-1-[5-(tert-butyl)-1,3,4-oxadiazol-2-yl]-3-methyl-1-butanol (v)
Reference 1:
    sorbera, l.a.; casta?er, j.; casta?er, r.m.; valganciclovir hydrochloride. drugs fut 2000, 25, 5, 474.
Reference 2:
    arzeno, h.b. (f. hoffmann-la roche ag); process for preparing purine derivs.. us 5700936; wo 9727195 .

Route 3
the reaction of ganciclovir (i) with trityl chloride in dmf in the presence of triethylamine and dmap gives the n,o-bis(trityl) compound (vi), which is condensed with the activated l-valine derivative (iii) by means of triethylamine in dmf/toluene to yield the expected valine ester (vii). finally, the trityl groups of (vii) are removed with tfa in trifluoroethanol to afford the previously reported monoprotected compound (iv). the condensation of the tritylated ganciclovir (vi) with n-(tert-butoxycarbonyl)-l-valine (viii) by means of dcc in dichloromethane gives the expected valine ester (ix), which is finally deprotected with tfa in dichloromethane. the valine ester (ix) can also be obtained by condensation of tritylated ganciclovir (vi) with n-(tert-butoxycarbonyl)-l-valine-n-carboxyanhydride (x) by means of triethylamine in dmf.
List of intermediates No.
3-sulfothiophene-2-carboxylic acid; 3-sulfo-2-thiophenecarboxylic acid (viii)
(3-[6-[3-(4-methoxyphenyl)-1,2-diboriran-3-yl]hexaboranyl]-1,2-diboriran-3-yl)methanol (iii)
2-(tert-butyl)-1,3,4-oxadiazole (i)
tert-butyl (1s)-1-[[5-(tert-butyl)-1,3,4-oxadiazol-2-yl](hydroxy)methyl]-2-methylpropylcarbamate (iv)
2-[5-[[(benzyloxy)carbonyl]amino]-6-oxo-2-phenyl-1(6h)-pyrimidinyl]acetic acid (vi)
benzyl 1-[2-([(1s)-1-[[5-(tert-butyl)-1,3,4-oxadiazol-2-yl](hydroxy)methyl]-2-methylpropyl]amino)-2-oxoethyl]-6-oxo-2-phenyl-1,6-dihydro-5-pyrimidinylcarbamate (ix)
benzyl 1-[2-[((1s)-1-[[5-(tert-butyl)-1,3,4-oxadiazol-2-yl]carbonyl]-2-methylpropyl)amino]-2-oxoethyl]-6-oxo-2-phenyl-1,6-dihydro-5-pyrimidinylcarbamate (x)
tert-butyl 2-[[imino(phenyl)methyl]amino]acetate (vii)
Reference 1:
    sorbera, l.a.; casta?er, j.; casta?er, r.m.; valganciclovir hydrochloride. drugs fut 2000, 25, 5, 474.
Reference 2:
    arzeno, h.b.; humphreys, e.r. (f. hoffmann-la roche ag); process for preparing purine derivs.. us 5756736; wo 9727196 .

Route 4
the reaction of ganciclovir (i) with trimethyl orthoformate and tfa in dmf gives the cyclic orthoester (xi), which is treated with formic acid in dmf/water to yield ganciclovir o-monoformate (xii). the condensation of (xii) with n-benzyloxycarbonyl-l-valine-n-carboxyanhydride (iii) by means of triethylamine in dmf affords the expected monovalinate (xiii), which is deformylated with hcl in methanol/dichloromethane to give the previously reported monoprotected valganciclovir derivative (iv).the preceding reaction sequence can also be performed by substituting trimethyl orthoformate with other orthoesters such as benzyl orthoformate, ethyl orthoacetate, methyl orthoacetate or ethyl orthopropionate.
List of intermediates No.
(3-[6-[3-(4-methoxyphenyl)-1,2-diboriran-3-yl]hexaboranyl]-1,2-diboriran-3-yl)methanol (iii)
2-(tert-butyl)-1,3,4-oxadiazole (i)
tert-butyl (1s)-1-[[5-(tert-butyl)-1,3,4-oxadiazol-2-yl](hydroxy)methyl]-2-methylpropylcarbamate (iv)
methyl (e)-3-methoxy-2-nitro-2-propenoate (xi)
2-[5-nitro-6-oxo-2-phenyl-1(6h)-pyrimidinyl]acetic acid (xii)
Reference 1:
    sorbera, l.a.; casta?er, j.; casta?er, r.m.; valganciclovir hydrochloride. drugs fut 2000, 25, 5, 474.
Reference 2:
    arzeno, h.b.; humphreys, e.r.; wong, j.-w.; roberts, c.r. (f. hoffmann-la roche ag); process for preparing ganciclovir derivs.. us 5840890; wo 9727197 .

Route 5
the condensation of 2-(acetoxymethoxy)-1,3-bis(benzyloxy)propane (xiv) with n2-acetylguanine (xv) by means of hexamethyldisilazane (hmds) and trifluoromethanesulfonic acid gives the n2-acetyl-o,o-dibenzylganciclovir (xvi), which is selectively monodebenzylated with either h2 over pd/c in methanol or cyclohexene and pd(oh)2 in refluxing ethanol, yielding intermediate (xvii), which by deacetylation with nh4oh in methanol affords mono-o-benzylganciclovir (xviii). the condensation of (xviii) with n-benzyloxycarbonyl-l-valine (xix) by means of dcc in dichloromethane gives the expected valine ester (xx), which is finally debenzylated with h2 over pd/c in methanol as before.
List of intermediates No.
2-iodoisophthalic acid (xix)
7-[(1,1-dimethyl-2-propynyl)oxy]-4-methyl-2(1h)-quinolinone (xiv)
tert-butyl 4,8,8-trimethyl-2-oxo-2h-pyrano[2,3-h]quinoline-1(8h)-carboxylate (xvi)
tert-butyl (9r,10r)-9,10-dihydroxy-4,8,8-trimethyl-2-oxo-9,10-dihydro-2h-pyrano[2,3-h]quinoline-1(8h)-carboxylate (xv)
2-[[imino(phenyl)methyl]amino]acetic acid (xvii)
n-allylbenzenecarboximidamide (xviii)
3-allyl-5-nitro-2-phenyl-4(3h)-pyrimidinone (xx)
Reference 1:
    nestor, j.j.; womble, s.w.; maag, h. (f. hoffmann-la roche ag); 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol deriv.. ca 2154721; ep 0694547; es 2083348; jp 1996041061; us 5840891; us 6083953 .
Reference 2:
    sorbera, l.a.; casta?er, j.; casta?er, r.m.; valganciclovir hydrochloride. drugs fut 2000, 25, 5, 474.
Reference 3:
    dvorak, c.a.; beard, c.c.; wren, d.l.; axt, s.d.; han, y.-k.; fatheree, p.r.; nguyen, s.l.; lund, j.p.; fisher, l.e.; arzeno, h.b.; humphreys, e.r. (f. hoffmann-la roche ag); process for preparing purine derivs.. us 6040446; wo 9727198 .

Route 6
the condensation of 1-acetoxy-2-(acetoxymethoxy)-3-(benzyloxy) propane (xxi) with guanine (xxii) by means of hmds and trifluoromethanesulfonic acid gives o-acetyl-o-benzylganciclovir (xxiii), which is deacetylated with naoh in methanol to yield the previously reported mono-o-benzylganciclovir (xviii).the preceding reaction sequence can also be performed by using 1-(benzyloxy)-2-(propionyloxymethoxy)-3-(propionyloxy)propane (xxiv) instead of compound (xxi), yielding intermediate (xxv) and finally the previously reported mono-o-benzylganciclovir (xviii).
List of intermediates No.
n,n-dipropylamine; n-propyl-1-propanamine (xxii)
n-allylbenzenecarboximidamide (xviii)
n-(2-furylmethyl)benzenecarboximidamide (xxi)
3-(2-furylmethyl)-5-nitro-2-phenyl-4(3h)-pyrimidinone (xxiii)
n-(2,2-dimethoxyethyl)benzenecarboximidamide (xxiv)
3-(2,2-dimethoxyethyl)-5-nitro-2-phenyl-4(3h)-pyrimidinone (xxv)
Reference 1:
    sorbera, l.a.; casta?er, j.; casta?er, r.m.; valganciclovir hydrochloride. drugs fut 2000, 25, 5, 474.
Reference 2:
    dvorak, c.a.; beard, c.c.; wren, d.l.; axt, s.d.; han, y.-k.; fatheree, p.r.; nguyen, s.l.; lund, j.p.; fisher, l.e.; arzeno, h.b.; humphreys, e.r. (f. hoffmann-la roche ag); process for preparing purine derivs.. us 6040446; wo 9727198 .

来源:药化网

作者:药化小编

摘要:本文合成路线介绍的是药物中文名缬更昔洛韦盐酸盐;英文名Valganciclovir hydrochloride;TA-9070;Ro-10-79070/194;RS-79070-194;RS-79070(free base);Valcyte;Valcyt;Cymeval;CAS[175865-59-5]

 
推荐VIP企业
无锡景耀生物科技有限公司
杭州卢普生物科技有限公司
宁波赛伦化工有限公司
苏州昊赛生物科技有限公司
北京嘉盛扬医药科技有限公司
上海泽涵生物医药科技有限公司
河北固安三利化工公司
郑州凯普瑞生物技术有限公司
上海药谷药业有限公司
兰州康寓信生物科技有限公司
湖北朗昕生化药业有限公司
武汉福鑫化工有限公司
嘉兴市英南化工有限公司
苏州迪飞医药科技有限公司
北京富安凯科技有限公司
上海盛中医药化工有限公司
连云港天和化学有限公司
南京晨瑞医药科技有限公司
南京苏如化工有限公司
常州瑞盛化工有限公司
热门文章
江苏地区粗苯价格暂稳
山东地区粗苯价格暂稳
华东地区丁二烯市场弱势盘整
浙江省化学农药使用量连续7年持
华东地区丁二烯市场价格走低
兴发集团实现草甘膦副产物高效高
华北地区BDO市场弱势延续
华南地区己二酸行情持稳
红太阳/丰山集团等8家农药生产
中国农民礼赞!——写在第一个“
我国化工园区第一个国家标准已获
浙江地区二氯甲烷价格暂稳
2018年智能制造试点示范项目
2018年秋播小麦种子药剂处理
内蒙古元正精细化工高效氟吡甲禾
农业农村部农药检定所征求《农药
刘学:浅析农药登记后再评价工作
华北地区丁二烯市场行情弱势
江西地区二氯甲烷价格暂稳
新安股份前三季度业绩预增,净利
 友情链接
有机化学人才网  
首页 | 广告服务 | 建站服务 | 关于我们 | 联系我们 | 版权声明